Targeting the epigenome and tumor heterogeneity: advances in immunotherapy for chemoresistant metastatic colorectal cancer
- DOI
- 10.3389/fimmu.2025.1623117
- Published
- 2025-12-01
- Container
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3389/fimmu.2025.1623117,
title = {Targeting the epigenome and tumor heterogeneity: advances in immunotherapy for chemoresistant metastatic colorectal cancer},
author = {Yu Cao and Narasimha M. Beeraka and Sergey K. Efetov and Zheng Liu and Akmalbek A. Otabekov and Basappa Basappa and Wensheng Wang and Dan Ma},
year = {2025},
journal = {Frontiers in Immunology},
doi = {10.3389/fimmu.2025.1623117},
url = {https://doi.org/10.3389/fimmu.2025.1623117}
}RIS
TY - JOUR TI - Targeting the epigenome and tumor heterogeneity: advances in immunotherapy for chemoresistant metastatic colorectal cancer AU - Yu Cao AU - Narasimha M. Beeraka AU - Sergey K. Efetov AU - Zheng Liu AU - Akmalbek A. Otabekov AU - Basappa Basappa AU - Wensheng Wang AU - Dan Ma PY - 2025 JO - Frontiers in Immunology DO - 10.3389/fimmu.2025.1623117 UR - https://doi.org/10.3389/fimmu.2025.1623117 ER -
APA
Cao, Y., Beeraka, N. M., Efetov, S. K., Liu, Z., Otabekov, A. A., Basappa, B., Wang, W., & Ma, D. (2025). Targeting the epigenome and tumor heterogeneity: advances in immunotherapy for chemoresistant metastatic colorectal cancer. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2025.1623117
Source records
- crossref · retrieved 2026-11-07T01:24:23.875Z